Business Wire

IL-ANGUS-LIFE-SCIENCES

Share
ANGUS Introduces New Excipient for Enhanced Purification of Large-Scale Drug Manufacturing

ANGUS Life Sciences , a newly formed division of ANGUS Chemical Company , the leading manufacturer and marketer of nitroalkanes and their derivatives, today launched TRIS AMINO® HCl PRIME – a new excipient used for purification of biologic or protein drug manufacturing. Used in downstream processes, TRIS AMINO HCl PRIME helps to control pH, offering stability and drug purification when manufacturing at large scales.

“As a result of the changing regulatory landscape, manufacturers may soon be required to monitor and report the levels of elemental impurities in their manufacturing processes. With TRIS AMINO HCl PRIME, our customers have peace of mind knowing there will be very low levels of elemental impurities,” said Doug Ward, market manager at ANGUS Life Sciences. “TRIS AMINO HCl PRIME adds to our rich history of buffer manufacturing and provides a new option for customers needing to control and report levels of elemental impurities.”

TRIS AMINO HCl PRIME offers the lowest levels of elemental impurities of any competitive product available. The total amount of heavy metals is less than one part per million, with individual elemental impurities measured in parts per billion.

“Our customers are seeking products that offer more purity in drug manufacturing,” said Dave Green, vice president of Research and Development. “TRIS AMINO HCl PRIME is a key example of how ANGUS, with its innovative technology, can fulfill our customers’ evolving needs. ANGUS is committed to seeking the highest standards of performance, and we feel fortunate to share this new offering with all our customers.”

Additional information on TRIS AMINO HCl PRIME can be found here: http://angus.com/markets/life-sciences/biotechnology/biotech-tris-amino

About ANGUS Life Sciences

ANGUS Life Sciences is a leader in servicing formulators and manufacturers in wide array of pharmaceutical, biotechnology and other life science applications. ANGUS Life Sciences develops products through a traceable and auditable supply chain of high-quality specialty and fine chemicals tailored to helping meet our customers’ biggest challenges. In addition to the TRIS AMINO buffer product line, ANGUS offers special testing, customized packaging and certification of biological buffers, biomolecules and biochemicals – a comprehensive line of quality offerings packaged in a cGMP and multi-compendia facility for complete satisfaction.

About ANGUS Chemical

ANGUS Chemical Company (“ANGUS”) is a specialty and fine chemical company dedicated to the development of novel chemistry that helps customers deliver enhanced product and process performance. ANGUS is committed to constantly improving products and services by mastering science and technology. The company innovates through its unique nitroalkane chemistry, which enables the reactivity to create complex molecules for use in a wide variety of applications. The innate characteristics of this chemistry enable multifunctional additives which improve performance, reduce reaction steps and cut synthesis costs.

Contact:

Chempetitive Group for ANGUS Chemical Company
Trisha Rule, 1-858-230-4949
anguspr@chempetitive.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Diagnostics.ai Launches Industry's First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect29.5.2025 08:13:00 CEST | Press release

CE-marked under the EU IVDR regulation, Diagnostics.ai's platform is the first to deliver algorithmic transparency and per-test auditability for clinical PCR diagnostics Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s first fully-transparent machine learning platform for clinical real-time PCR diagnostics – demonstrating exactly how each result was achieved, a first for molecular-testing machine learning. The technology is backed by over 15 years of experience and millions of successfully processed samples with >99.9% proven accuracy. The CE-IVDR Strategic Advantage Platform is Diagnostics.ai's response to the new wave of stringent EU regulations under the In Vitro Diagnostic Medical Devices Regulation (IVDR), which demand heightened standards for diagnostic accuracy, reproducibility, and algorithm transparency. “While most diagnostic algorith

From Ancient Grounds to an Intelligent Future: The 1st International Humanoid Olympiad Launches in Olympia, Greece29.5.2025 00:47:00 CEST | Press release

This year, Olympia, Greece, the birthplace of the Olympic Games, welcomes the inaugural International Humanoid Olympiad. From August 29th to September 2nd, at the International Olympic Academy in Olympia, humanoid robots will participate in demonstrations and Olympic-inspired games, showcasing their dexterity and intelligence, while global leaders in robotics and AI will share insights through expert talks and workshops. Blending millennia-old values, ethos, and ideals with a bold vision for the future, the event will spotlight how human creativity and robotics are shaping the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528788233/en/ This global gathering brings together state-of-the-art humanoid robots in spectacular showcases designed to captivate audiences of all ages and backgrounds while their creators, researchers, engineers, students, and visionaries are pushing the boundaries of what intelligent machine

Mary Kay Inc. Awards 10 Grants to Young Innovators at 2025 Regeneron International Science and Engineering Fair28.5.2025 22:29:00 CEST | Press release

Mary Kay Inc., a global advocate for furthering young women’s education and encouraging youth to follow their STEM dreams, returned for a second year as a Special Awards Organization at the Regeneron International Science and Engineering Fair (Regeneron ISEF) in Columbus, Ohio. Ten grants totaling nearly $10,000 were awarded to standout high school-aged students excelling in innovative projects spanning topics from finding cures for cancers affecting women to sustainable packaging innovation and protecting our planet’s most valuable resources. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528325390/en/ Kristin Dasaro, Director, Package Engineering and Sustainability at Mary Kay, greets Brazilian cancer researcher, Carolina de Araujo Pereira da Silva, who received back-to-back awards from Mary Kay for innovative findings in the malignancy of tumors. (Photo Credit: Mary Kay Inc.) Each year, the event convenes nearly 2,000

Duravant Completes Acquisition of Pattyn28.5.2025 19:44:00 CEST | Press release

Automation Equipment Leader Duravant expands Packaging Group with Acquisition of Pattyn Duravant LLC (“Duravant”), a global engineered equipment and automation solutions provider to the protein processing, food sorting and handling, packaging, and material handling sectors, announced the completion of its acquisition of the Pattyn Group BV (“Pattyn”), a leading manufacturer of packaging automation systems headquartered in Bruges, Belgium. The transaction was first announced on February 7, 2025, and was completed today. With over 70 years of expertise, Pattyn is a trusted partner for companies looking to automate bulk packaging operations in industries ranging from food and ingredients to non-food applications. Pattyn has been a world-renowned brand specializing in bag-in-box packaging technology, and their comprehensive end-of-line solutions span the entire packaging process from case erecting and bag inserting to weigh filling, bag and case closing, and palletizing. “We are extremely

Rimini Street Appoints Vijay Kumar as EVP and Chief Operating Officer28.5.2025 18:00:00 CEST | Press release

Seasoned business and IT executive leader to drive operational efficiency, scaling, increased profitability and accelerated growth of the business Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the appointment of Vijay Kumar as executive vice president (EVP) and chief operating officer (COO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528704180/en/ Rimini Street Appoints Vijay Kumar as EVP and Chief Operating Officer In this role, Mr. Kumar leads product management, service strategy and offerings for Rimini Street’s “Support, Optimize and Innovate” solutions and oversees Rimini Street’s Global Capability Centers (GCC). Mr. Kumar also drives operational efficiency and innovation of the portfolio to increase profitability and accelerate t

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye